 |
| |
 | | Hospitalization | |
|
Hospitalize patients presenting with respiratory, hemodynamic, or neurologic dysfunction.  |
- Hospitalize patients with suspected nerve agent exposure with respiratory distress, excessive pulmonary secretions, hemodynamic instability, neuromuscular weakness and fasciculations, or mental state changes.
- Even if cholinergic signs appear to improve, monitor for 2 to 3 days for neuromuscular weakness, especially in the neck and respiratory muscles.
- Do not hospitalize patients exhibiting only miosis and no other symptoms and signs of nerve agent poisoning.
| Background
| | | FAQs |
|
| Christine M. Stork, PharmD, DABAT has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Elliot Rodriguez, MD, FACEP has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Jerrold B. Leikin, MD, editorial consultant, received royalties from McGraw-Hill, Taylor and Francis; editor of Toxicoterrorism (McGraw-Hill).
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott. |
|
|
|
The information included herein should never be used as a substitute
for clinical judgment and does not represent an official position of
ACP. Because all PIER modules are updated regularly, printed web pages
or PDFs may rapidly become obsolete. Therefore, PIER users should
compare the date of the last update on the website with any printout
to ensure that the information being referred to is the most current
available.
|
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.
|
|
|
Nerve Agent Exposure
